期刊
ALZHEIMERS & DEMENTIA
卷 13, 期 12, 页码 1364-1370出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jalz.2017.04.012
关键词
Alzheimer's disease; Cancer; Epidemiology; Inverse association; Risk; Chemotherapy; Radiation; Cancer therapy; Survival bias
资金
- VA Merit Review Award [I01CX000934-01A1]
- NIH [T32 NS048005]
- Harvard NeuroDiscovery Center
- Harvard Catalyst [NIH UL1 TR001102]
Introduction: To examine the risk of Alzheimer's disease (AD) among cancer survivors in a national database. Methods: Retrospective cohort of 3,499,378 mostly male US veterans aged >= 65 years were followed between 1996 and 2011. We used Cox models to estimate risk of AD and alternative outcomes (non-AD dementia, osteoarthritis, stroke, and macular degeneration) in veterans with and without a history of cancer. Results: Survivors of a wide variety of cancers had modestly lower AD risk, but increased risk of the alternative outcomes. Survivors of screened cancers, including prostate cancer, had a slightly increased AD risk. Cancer treatment was independently associated with decreased AD risk; those who received chemotherapy had a lower risk than those who did not. Discussion: Survivors of some cancers have a lower risk of AD but not other age-related conditions, arguing that lower AD diagnosis is not simply due to bias. Cancer treatment may be associated with decreased risk of AD. Published by Elsevier Inc. on behalf of the Alzheimer's Association.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据